Executive Summary

The rapid evolution of artificial intelligence (AI), data analytics, genomics, and wearable technology has redefined modern healthcare. Since the COVID-19 pandemic catalyzed digital adoption, global health technology has become one of the most dynamic and transformative industries in the world, driving innovation from diagnostics to personalized treatment. With annual global digital health investments surpassing $25 billion, the convergence of private capital, public–private partnerships, and emerging regulation has created both opportunities and challenges. As AI-powered platforms reshape patient care and expand preventive health, ensuring data security, equitable access, and responsible governance is vital. Strategic federal investment and thoughtful regulation can accelerate innovation while safeguarding patient well-being and U.S. leadership in health technology.

Background

Over the past two decades, health technology has experienced exponential growth driven by breakthroughs in AI diagnostics, data science, wearable sensors, and genomic sequencing. The COVID-19 pandemic served as an inflection point, normalizing telehealth, remote monitoring, and digital therapeutics as integral components of healthcare delivery. Global investment momentum continues to rise, and startups and multinational corporations alike are developing AI-based diagnostic tools and predictive analytics platforms to enhance clinical outcomes and operational efficiency. Public–private partnerships that link government agencies, hospitals, and technology firms are accelerating commercialization and integration of these innovations across healthcare systems. Notable examples include Midi Health, which recently raised $50 million in Series C funding to expand AI-powered virtual care for women’s midlife health, and Samsung’s acquisition of U.S. digital health platform Xealth, connecting hospitals and patients through wearable-integrated digital programs. These developments illustrate how innovation in the private sector can drive inclusive, personalized, and data-driven healthcare ecosystems.

Challenges

Despite immense potential, the health technology sector faces several structural and ethical challenges. Health technology spans medical devices, software, and pharmaceuticals, yet regulation remains fragmented. While the 21st Century Cures Act supports innovation by accelerating approval pathways, implementation lags for emerging technologies such as digital therapeutics and AI diagnostics. As patient data becomes the foundation for predictive health systems, HIPAA remains a critical but incomplete safeguard. The growing use of algorithmic models raises new privacy, transparency, and accountability concerns that current HIPAA frameworks struggle to address. Furthermore, without reimbursement standards, many digital therapeutics and AI-driven care models remain inaccessible to lower-income and rural populations. The Access to Prescription Digital Therapeutics Act of 2025 seeks to bridge this gap, but broader insurance integration is needed. Major technology companies dominate data infrastructure and hardware ecosystems, risking consolidation that may disadvantage smaller innovators and limit patient choice. Balancing innovation with regulation, particularly around AI validation, ethical data use, and reimbursement, is central to sustaining health technology’s long-term societal benefits.

Solutions

Several legislative efforts aim to address these emerging needs. The Safeguarding Therapeutics Act, which could strengthen supply chain security for medical products, seeks to ensure the integrity of digital and physical components alike. The Access to Prescription Digital Therapeutics Act of 2025 proposes federal reimbursement frameworks for clinically validated digital therapies, incentivizing patient access and payer adoption. The Health Information Privacy Reform Act seeks to provide additional privacy, security, and breach notification protections for health information processed by entities not currently covered by HIPAA, while also clarifying individual rights regarding the access and transmittal of protected health records. Collaborative innovation between the public and private sectors is essential. Hospitals, startups, insurers, and technology companies must align on interoperability, outcome transparency, and cybersecurity. Federal support for open standards and research funding would further strengthen the ecosystem while mitigating risks of fragmentation or exploitation.

Policy Recommendations

To secure U.S. leadership in the next generation of health technology and ensure equitable access for
all citizens, Congress and federal agencies should:

1. Adopt HIPRA frameworks to address AI-driven analytics, wearable data streams, and predictive
   modeling transparency.

2. Establish a national digital therapeutics reimbursement standard to ensure equitable access.

3. Expand the 21st Century Cures framework to include adaptive regulatory sandboxes for
   emerging technologies like generative AI and genomic personalization.

4. Incentivize public–private partnerships to develop ethical AI models and shared data
   infrastructure while safeguarding privacy.

5. Encourage cross-sector collaboration between hospitals, startups, and insurers to drive
   interoperable, patient-centric solutions.
   By embracing these initiatives, the U.S. can foster an ecosystem where innovation and ethics advance
   together, delivering personalized, secure, and equitable healthcare for future generations. The
   continued investment in health technology not only strengthens national resilience but also reaffirms
   America’s role as a global leader in medical innovation.